These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 16133411)
1. Molecular epidemiology of hepatitis C among drug users in Flanders, Belgium: association of genotype with clinical parameters and with sex- and drug-related risk behaviours. Matheï C; Wollants E; Verbeeck J; Van Ranst M; Robaeys G; Van Damme P; Buntinx F Eur J Clin Microbiol Infect Dis; 2005 Aug; 24(8):514-22. PubMed ID: 16133411 [TBL] [Abstract][Full Text] [Related]
2. Distribution of hepatitis C virus genotypes among injecting drug users in contact with treatment centers in Belgium, 2004-2005. Micalessi MI; Gérard C; Ameye L; Plasschaert S; Brochier B; Vranckx R J Med Virol; 2008 Apr; 80(4):640-5. PubMed ID: 18297717 [TBL] [Abstract][Full Text] [Related]
3. Molecular epidemiology of hepatitis C virus among injection drug users in Iran: a slight change in prevalence of HCV genotypes over time. Samimi-Rad K; Nasiri Toosi M; Masoudi-Nejad A; Najafi A; Rahimnia R; Asgari F; Shabestari AN; Hassanpour G; Alavian SM; Asgari F Arch Virol; 2012 Oct; 157(10):1959-65. PubMed ID: 22695769 [TBL] [Abstract][Full Text] [Related]
4. Prevalence and genotypes of hepatitis C virus infection among drug addicts and blood donors in Thailand. Verachai V; Phutiprawan T; Theamboonlers A; Chinchai T; Tanprasert S; Haagmans BL; Osterhaus AD; Poovorawan Y Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):849-51. PubMed ID: 12757237 [TBL] [Abstract][Full Text] [Related]
5. Change in hepatitis C virus genotype in injecting drug users. Aitken C; McCaw R; Jardine D; Bowden S; Higgs P; Nguyen O; Crofts N; Hellard M J Med Virol; 2004 Dec; 74(4):543-5. PubMed ID: 15484265 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis C seroprevalence amongst injecting drug users attending a methadone programme. Chetwynd J; Brunton C; Blank M; Plumridge E; Baldwin D N Z Med J; 1995 Sep; 108(1007):364-6. PubMed ID: 7566775 [TBL] [Abstract][Full Text] [Related]
7. Trends in HCV prevalence, risk factors and distribution of viral genotypes in injecting drug users: findings from two cross-sectional studies. Oliveira ML; Yoshida CF; Telles PR; Hacker MA; Oliveira SA; Miguel JC; do O KM; Bastos FI Epidemiol Infect; 2009 Jul; 137(7):970-9. PubMed ID: 19144250 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus subtype diversity and transmission clusters characteristics among drug users in Zhuhai, South China. Li H; Huang H; Huang W; Du M; Long D; Xu G; Mei W; Huang K BMC Infect Dis; 2024 Apr; 24(1):451. PubMed ID: 38685009 [TBL] [Abstract][Full Text] [Related]
9. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots. Hope VD; Hickman M; Ngui SL; Jones S; Telfer M; Bizzarri M; Ncube F; Parry JV J Viral Hepat; 2011 Apr; 18(4):262-70. PubMed ID: 20456636 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis C genotype distribution and homology among geographically disparate injecting drug users in Afghanistan. Sanders-Buell E; Rutvisuttinunt W; Todd CS; Nasir A; Bradfield A; Lei E; Poltavee K; Savadsuk H; Kim JH; Scott PT; de Souza M; Tovanabutra S J Med Virol; 2013 Jul; 85(7):1170-9. PubMed ID: 23918535 [TBL] [Abstract][Full Text] [Related]
11. Epidemiological and genetic analyses of Hepatitis C virus transmission among young/short- and long-term injecting drug users from Rio de Janeiro, Brazil. Oliveira Mde L; Bastos FI; Telles PR; Hacker Mde A; Oliveira SA; Miguel JC; Yoshida CF J Clin Virol; 2009 Mar; 44(3):200-6. PubMed ID: 19195927 [TBL] [Abstract][Full Text] [Related]
12. Prevalence and associated clinical characteristics of hepatitis B, C, and HIV infections among injecting drug users in Korea. Min JA; Yoon Y; Lee HJ; Choi J; Kwon M; Kim K; Lee CU; Kim DJ; Yun H J Med Virol; 2013 Apr; 85(4):575-82. PubMed ID: 23364858 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus molecular epidemiology in Uzbekistan. Kurbanov F; Tanaka Y; Sugauchi F; Kato H; Ruzibakiev R; Zalyalieva M; Yunusova Z; Mizokami M J Med Virol; 2003 Mar; 69(3):367-75. PubMed ID: 12526047 [TBL] [Abstract][Full Text] [Related]
14. High prevalence of genotype 4 among hepatitis C virus-infected intravenous drug users in north-eastern Poland. Chlabicz S; Flisiak R; Kowalczuk O; Wiercińska-Drapalo A; Pytel-Krolczuk B; Prokopowicz D; Chyczewski L J Med Virol; 2008 Apr; 80(4):615-8. PubMed ID: 18297715 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of hepatitis C virus infection and associated factors among male illicit drug users in Cuiabá, Mato Grosso, Brazil. Novais AC; Lopes CL; Reis NR; Silva AM; Martins RM; Souto FJ Mem Inst Oswaldo Cruz; 2009 Sep; 104(6):892-6. PubMed ID: 19876562 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus infection among illicit drug users in an archipelago of the Amazon. Silva FQ; Santos FJA; Andrade AP; Pacheco SDB; Fischer B; Pinho JRR; Lemos JAR; Oliveira-Filho AB Arch Virol; 2018 Mar; 163(3):617-622. PubMed ID: 29164400 [TBL] [Abstract][Full Text] [Related]
17. Epidemiological distribution and genotype characterization of hepatitis C virus and HIV co-infection in Wuhan, China, where the prevalence of HIV is low. Zhao R; Peng J; Tang L; Huang H; Liu M; Kong W; Pang B J Med Virol; 2013 Oct; 85(10):1712-23. PubMed ID: 23868809 [TBL] [Abstract][Full Text] [Related]
18. Epidemiological aspects of HCV infection in non-injecting drug users in the Brazilian state of Pará, eastern Amazon. Oliveira-Filho AB; Sawada L; Pinto LC; Locks D; Bahia SL; Castro JA; Hermes RB; Brasil-Costa I; Amaral CE; Lemos JA Virol J; 2014 Feb; 11():38. PubMed ID: 24564954 [TBL] [Abstract][Full Text] [Related]
19. Molecular epidemiology of hepatitis C virus genotypes and subtypes among injecting drug users in Hungary. Tresó B; Takács M; Dencs Á; Dudás M; Pár A; Rusvai E Euro Surveill; 2013 Nov; 18(47):. PubMed ID: 24300886 [TBL] [Abstract][Full Text] [Related]
20. Prevalence, risk factors and genotypes of hepatitis C virus infection among drug users, Central-Western Brazil. Lopes CL; Teles SA; Espírito-Santo MP; Lampe E; Rodrigues FP; Motta-Castro AR; Marinho TA; Reis NR; Silva AM; Martins RM Rev Saude Publica; 2009 Aug; 43 Suppl 1():43-50. PubMed ID: 19669064 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]